The NordICC-study group is nominated for the category Best Scientific Work by the Felix Burda Award 2017

Centre PI Michael Bretthauer and the NordICC-study group is nominated for the prestigious German research prize The Felix Burda Award 2017 for Best Scientific Work. The prize is awarded in Berlin on the 14 of May at a gala venue broadcasted on German television.

Principal investigator Michael Bretthauer

Link to news article in Norwegian from the The Clinical Effectiveness Research Group homepage: Norske leger nominert til prestisjetung tysk forskningspris

Latest publications

Berg et al. 2019. Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains. Oncogene [Epub ahead of print] Sveen A, Kopetz S, Lothe RA. 2019. Biomarker-guided therapy for colorectal cancer: strength in complexity. Nat. Rev. Clin. Oncol. [Epub ahead of print] Marcuello et al. 2019. Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol. Asp. Med. [Epub ahead of print] Smeby et al. 2019. Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer. Oncogenesis 8(6): 35 Kryeziu et al., 2019. Combination therapies with HSP90 inhibitors against colorectal cancer. BBA Reviews on Cancer, 1871(2): 240-247 All publications